The First Pentacyclic Triterpenoid Gypsogenin Derivative Exhibiting Anti-ABL1 Kinase and Anti-chronic Myelogenous Leukemia ActivitiesHalil I. Ciftci(Kumamoto University), Mikako Fujita(Burdur Mehmet Akif Ersoy Üniversitesi)Biological and Pharmaceutical BulletinJanuary 1, 201810.1248/bpb.b17-00902Cited by 49SaveCiteExport RISWatch citationsRelated PapersDiscovery of Azaindolin-2-One as a Dual Inhibitor of GSK3β and Tau Aggregation with Potential Neuroprotective Activity|Pharmaceuticals|2022|7Discovery of Cytotoxic Truncated Vitamin D Derivatives Against Both Bortezomib‐Sensitive and Resistant Multiple Myeloma Phenotypes|Research Square|2024|0